CRDL vs. INVZ
CRDL (Cardiol Therapeutics Inc Class A) and INVZ (Innoviz Technologies Ltd.) are both stocks. CRDL operates in Drug Manufacturers - Specialty & Generic (Healthcare), while INVZ operates in Auto Parts (Consumer Cyclical). Over the past 5 years, CRDL returned -10.81%/yr vs -45.89%/yr for INVZ. Their 0.20 correlation means their historical movements had little consistent relationship.
Performance
CRDL vs. INVZ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRDL achieves a 33.15% return, which is significantly higher than INVZ's -49.71% return.
CRDL
- 1D
- 4.96%
- 1M
- 20.95%
- 6M
- 33.59%
- YTD
- 33.15%
- 1Y
- -7.97%
- 3Y*
- 5.39%
- 5Y*
- -10.81%
- 10Y*
- —
- ALL TIME*
- -13.35%
INVZ
- 1D
- 1.85%
- 1M
- -38.07%
- 6M
- -55.39%
- YTD
- -49.71%
- 1Y
- -71.01%
- 3Y*
- -52.61%
- 5Y*
- -45.89%
- 10Y*
- —
- ALL TIME*
- -44.39%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.01M | $1.10M | $670.12K | |
| $1.96M | $1.54M | $2.22M |
CRDL vs. INVZ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
CRDL Cardiol Therapeutics Inc Class A | 33.15% | -25.48% | 51.80% | 65.33% | -72.43% | -47.29% |
INVZ Innoviz Technologies Ltd. | -49.71% | -49.22% | -33.60% | -35.62% | -38.01% | -34.84% |
Correlation
The correlation between CRDL and INVZ is 0.25, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.25 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 5, 2021 | 0.20 |
Fundamentals
CRDL:
$146.40M
INVZ:
$94.97M
CRDL:
-CA$0.37
INVZ:
-$0.39
CRDL:
9.98
INVZ:
1.55
CRDL:
CA$0.00
INVZ:
$44.83M
CRDL:
-CA$25.95K
INVZ:
$4.34M
CRDL:
-CA$34.00M
INVZ:
-$73.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRDL vs. INVZ — Risk / Return Rank
CRDL
INVZ
CRDL vs. INVZ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cardiol Therapeutics Inc Class A (CRDL) and Innoviz Technologies Ltd. (INVZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRDL | INVZ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.56 | ||
| Sortino ratioReturn per unit of downside risk | +1.49 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 0.85 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.38 | -0.86 | +0.48 |
| Martin ratioReturn relative to average drawdown | -0.61 | -1.31 | +0.70 |
Loading charts...
Drawdowns
CRDL vs. INVZ - Drawdown Comparison
The maximum CRDL drawdown since its inception was -92.71%, roughly equal to the maximum INVZ drawdown of -96.92%. Use the drawdown chart below to compare losses from any high point for CRDL and INVZ.
Loading charts...
Drawdown Indicators
| CRDL | INVZ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -92.71% | -96.92% | +4.21% |
Max Drawdown (1Y)Largest decline over 1 year | -39.14% | -84.03% | +44.89% |
Max Drawdown (3Y)Largest decline over 3 years | -72.73% | -89.76% | +17.03% |
Max Drawdown (5Y)Largest decline over 5 years | -90.72% | -96.02% | +5.30% |
Current DrawdownCurrent decline from peak | -79.48% | -96.53% | +17.05% |
Average DrawdownAverage peak-to-trough decline | -69.21% | -75.37% | +6.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.12% | 55.26% | -27.14% |
Volatility
CRDL vs. INVZ - Volatility Comparison
The current volatility for Cardiol Therapeutics Inc Class A (CRDL) is 19.68%, while Innoviz Technologies Ltd. (INVZ) has a volatility of 43.07%. This indicates that CRDL experiences smaller price fluctuations and is considered to be less risky than INVZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRDL | INVZ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.68% | 43.07% | -23.39% |
Volatility (6M)Calculated over the trailing 6-month period | 42.48% | 67.49% | -25.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 66.24% | 92.96% | -26.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 87.05% | 91.13% | -4.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.49% | 90.01% | -3.52% |
Dividends
CRDL vs. INVZ - Dividend Comparison
Neither CRDL nor INVZ has paid dividends to shareholders.
Financials
CRDL vs. INVZ - Financials Comparison
This section allows you to compare key financial metrics between Cardiol Therapeutics Inc Class A and Innoviz Technologies Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRDL and INVZ have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
INVZ has higher volatility (43.07%) compared to CRDL (19.68%). In terms of maximum drawdown, CRDL dropped -92.71% vs INVZ's -96.92%.
CRDL currently has the higher Sharpe Ratio (-0.22 vs -0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRDL and INVZ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer